Fortis Healthcare Capacity Expansion
Fortis Healthcare expands into Odisha via an O&M deal for a 300-bed hospital in Cuttack. This asset-light model marks its first major presence in the state.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
42 announcements with these filters
Fortis Healthcare expands into Odisha via an O&M deal for a 300-bed hospital in Cuttack. This asset-light model marks its first major presence in the state.
Fortis Healthcare filed its Annual Secretarial Compliance Report for FY 2025-26. The company reported high compliance, with one minor administrative penalty of ₹35,400 paid.
Fortis reported strong FY26 performance with 17.3% revenue growth and 31.5% PAT growth. Strategy focuses on brownfield expansion and diagnostic margin improvement.
Fortis Healthcare recommended a final dividend of 0.1 per equity share for FY 2025-26. The record date and general meeting details will be announced later.
Fortis Healthcare Limited appointed M/s. Jitender, Navneet & Co. as Cost Auditors for a 12-month tenure. The experienced firm's appointment ensures statutory costing compliance.
Fortis Healthcare reported consolidated revenue of ₹9,128 Crore for FY26, marking a 17.3% growth. The board recommended a dividend of ₹1 per share for shareholders.
Fortis Healthcare Ltd reported revenue from operations of ₹2,365 Cr (+17.8% YoY) and net profit of ₹271.2 Cr (+44.3% YoY) for Q4 FY26.
Fortis Healthcare approved FY26 financial results and recommended a ₹1 per share final dividend. The dividend involves a ₹7.55 Crore cash outflow, reflecting stable shareholder returns.
Fortis Healthcare provided an update on litigation filed by its promoter, Northern TK Venture, against Daiichi Sankyo in Japan. The Tokyo District Court has concluded proceedings, with a judgment scheduled for September 10, 2026. This follow-up stems from an April 28, 2026, announcement by IHH Healthcare Berhad regarding the same matter.
Fortis Healthcare Limited approved the grant of 1,32,05,200 stock options to eligible employees under its ESOP 2026 scheme. The options have an exercise price of INR 923.10 each. This move aims to align employee interests with long-term shareholder value and talent retention.
Fortis Healthcare Limited submitted its annual centralized database disclosure for Non-Convertible Debentures (NCDs) for FY 2025-26. The filing details three NCD series totaling ₹1,550 Crore, including listing information, credit rating upgrades to CRISIL AA+, and confirmation of timely annual interest payments made on December 22, 2025.
Fortis Healthcare Limited reported details of its listed debt securities totaling ₹1,550 Crore as of March 31, 2026. The NCDs were issued in December 2024 with a maturity date of December 19, 2029. The securities carry an initial coupon rate of 7.7648% p.a., subject to annual resets.